From: Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study
Non-compliant
Compliant
Total
N
%
Very bad
9
14.3
10.1
18
11.8
Bad
10
15.9
8
9.0
Indifferent
13
20.6
29
32.6
42
27.6
Good
21
33.3
27
30.3
48
31.6
Very good
16
18.0
26
17.1
63
100.0
89
152